Blood Cancer (Hematology/Oncology)

If you are diagnosed with leukemia, lymphoma, multiple myeloma, or another type of blood cancer, you can be assured of the highest quality care from the experienced hematology specialists at the Lahey Health Cancer Institute (LHCI). We offer a patient-centered approach that is comprehensive and attentive.

Leukemia, Lymphoma, Myeloma

LHCI’s hematologists treat all blood-related conditions and have extensive experience in diagnosing and treating blood cancer including:

  • Leukemia – Cancer of your blood or bone marrow, affecting your body’s ability to fight infections
  • Lymphoma – Cancer of your lymph nodes that starts in your white blood cells
  • Multiple myeloma – Cancer that develops from cells in your bone marrow called plasma cells

At Lahey, you will receive hands-on care for leukemia, lymphoma, myeloma, or other blood cancers from experienced and compassionate providers.

Learn about our services and treatments, including autologous stem cell transplants.

Experience and Expertise in Blood Cancer

Our board-certified hematologists exclusively treat diseases of the blood and bone marrow and also perform blood cancer research. Our hematology team provides the most current cancer treatments and can offer you access to cancer clinical trials if you so desire.

The LHCI hematology team holds weekly conferences to review all care plans and treatments, and monthly meetings to share expertise and advice with colleagues. Lahey also offers ongoing support groups for people with blood disorders that are open to anyone, regardless of where they are receiving their care.

Meet our hematology/oncology team.

National Accreditation, Quality Standards

Lahey’s autologous stem cell transplant (ASCT) program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), an internationally recognized accrediting body for medical institutions that perform stem cell transplants.

This accreditation indicates that Lahey’s ASCT program has met the most rigorous standards for every aspect of stem cell therapy. The inspection process evaluates the clinical care in the hospital and outpatient clinic as well as the collection, processing, storage, and infusion of blood cells, and is a sign of a quality program.

Lahey’s outcomes and patient satisfaction scores are excellent, exceeding nationally established benchmarks.